Evaluation of ocular surface following PreserFlo Microshunt implantation: Functional outcomes and quality of life.

Gloria GambiniMatteo Mario CarlàFederico GiannuzziAlfonso Savastano Tomaso CaporossiAntonio BaldascinoDanilo IannettaLorenzo VielmoStanislao Rizzo

Published in: Clinical & experimental ophthalmology (2023)

PreserFlo implantation improved ocular surface subjective symptoms, increased TBUT and ST, and reduced FS, highlighting the potential benefits of this surgical intervention. Moreover, we reported significant improvements of tear osmolarity and corneal epithelium.

Keyphrases

randomized controlled trial
sleep quality
optical coherence tomography
human health
depressive symptoms